Research Paper Volume 14, Issue 9 pp 4158—4175
CCL19 has potential to be a potential prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA database
Figure 5. The survival analysis, differential analysis and GSEA of CCL19. (A) The survival analysis between the expression of CCL19 and the survival of breast cancer patients; patients were divided into two groups, high CCL19 expression group and low CCL19 expression group, compared with the median; (B–F) The associations between the expression of CCL19 with age, stage, and TNM classification of breast cancer patients; p value was displayed in the diagram; (G–J) GSEA for genes in high CCL19 expression group in different gene sets, p<0.05 and FDR<0.05 were considered to be statistically significant.